| β | SE | Exp(β) | 95% CI | p Value | |
---|---|---|---|---|---|---|
LCL | UCL | |||||
SF-36v2 | ||||||
 MCS Scorea | −1.157 | 0.088 | NA | −1.330 | −0.983 | <0.001 |
 PCS Scorea | −1.262 | 0.071 | NA | −1.401 | −1.123 | <0.001 |
 SF-6D Utility Scorea | −0.017 | 0.001 | NA | −0.018 | −0.015 | <0.001 |
EQ-5D-5L | ||||||
 EQ-5D-5L Index Scorea | −0.016 | 0.001 | NA | −0.019 | −0.013 | <0.001 |
 EQ-5D-5L VAS Scorea | −2.263 | 0.194 | NA | −2.643 | −1.884 | <0.001 |
Depression | ||||||
 PHQ-9 Scorea | 0.117 | 0.008 | 1.124 | 0.101 | 0.133 | <0.001 |
 Moderate to Severe Depression Symptomsb | 0.270 | 0.031 | 1.309 | 1.233 | 1.391 | <0.001 |
Anxiety | ||||||
 GAD-7 Scorea | 0.114 | 0.011 | 1.121 | 0.092 | 0.136 | <0.001 |
 Moderate to Severe Anxiety Symptomsb | 0.227 | 0.034 | 1.255 | 1.173 | 1.342 | <0.001 |
PDQ-5 Scorea | 0.726 | 0.030 | NA | 0.666 | 0.785 | <0.001 |
Overall Treatment Satisfactiona,c | −0.068 | 0.0197 | NA | −0.106 | −0.029 | 0.001 |